News-Medical.Net on MSN
New CHEST guidelines offer evidence-based biologic selection for severe asthma
The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...
The American College of Pulmonologists has published new clinical guidelines for the use of biological therapy in severe ...
The American College of Chest Physicians released a new clinical guideline on biologic management in severe asthma containing seven evidence-based recommendations.
Oral corticosteroids, although effective, pose significant adverse effects and health care costs, necessitating clear tapering guidelines and alternative treatments. Biologics significantly reduce ...
Please provide your email address to receive an email when new articles are posted on . The questionnaire assessed general fatigue, sleep-rest fatigue and cognitive fatigue. Asthma-related quality of ...
Severe asthma is already treatable with a monthly injectable GSK drug, the blockbuster product Nucala. A new FDA approval gives the drugmaker the opportunity to reach patients with a different ...
Mepolizumab significantly reduces exacerbations in patients with asthma and concurrent chronic obstructive pulmonary disease (COPD), with a 55% reduction in COPD exacerbations post initiation. A ...
GPs have been advised to stop prescribing blue reliever inhalers alone for newly-diagnosed asthma. Instead, they should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to ...
Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) diseases that cause breathing difficulty and coughing. Asthma affects about 28 million people in the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results